Provided by Tiger Fintech (Singapore) Pte. Ltd.

Medpace

306.07
+8.262.77%
Volume:359.17K
Turnover:109.45M
Market Cap:8.80B
PE:23.38
High:307.76
Open:297.86
Low:294.95
Close:297.81
Loading ...

Zealand Pharma Appoints Steven Johnson as Chief Development Officer to Bolster Leadership in Obesity Treatment Innovation

Reuters
·
19 May

William Blair Remains a Hold on Medpace Holdings (MEDP)

TIPRANKS
·
19 May

Medpace Holdings Approves Key Proposals at Annual Meeting

TIPRANKS
·
17 May

Is Healthcare Losing the Status of Safe Haven? ETFs in Focus

Zacks
·
30 Apr

Healthcare stocks: No longer a safe space for investors?

Yahoo Finance
·
28 Apr

Stock Track | Medpace Holdings Soars 5.12% Pre-Market on Strong Q1 2025 Earnings Beat

Stock Track
·
23 Apr

Medpace Holdings Is Maintained at Neutral by Baird

Dow Jones
·
23 Apr

Deutsche Bank Adjusts Medpace Holdings Price Target to $270 From $280, Maintains Hold Rating

MT Newswires Live
·
23 Apr

Medpace Holdings First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
23 Apr

U.S. RESEARCH ROUNDUP-3M, Intuit, Starbucks

Reuters
·
23 Apr

Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive ...

GuruFocus.com
·
23 Apr

Medpace Holdings: Hold Rating Amid Mixed Financial Results and Demand Concerns

TIPRANKS
·
23 Apr

Q1 2025 Medpace Holdings Inc Earnings Call

Thomson Reuters StreetEvents
·
23 Apr

Medpace Holdings Reports Strong Q1 2025 Results

TIPRANKS
·
23 Apr

Why Medpace (MEDP) Stock Is Trading Lower Today

StockStory
·
23 Apr

Medpace Holdings Cut to Market Perform From Outperform by William Blair

Dow Jones
·
22 Apr

Medpace downgraded to Market Perform at William Blair amid uncertainty

TIPRANKS
·
22 Apr

Stock Track | Medpace Plummets 13.24% in Pre-market Trading: Weak Guidance and Slowing Business Momentum Overshadow Strong Q1 Results

Stock Track
·
22 Apr

Stock Track | Medpace Plummets 13.24% as Conservative Guidance and Slowing Momentum Overshadow Strong Q1 Results

Stock Track
·
22 Apr

Deutsche Bank Adjusts Medpace Price Target to $280 From $325, Maintains Hold Rating

MT Newswires Live
·
22 Apr